A5031290927- Cervical Cancer and HPV Research
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Reproductive tract infections research
- Hepatitis B Virus Studies
- Endometrial and Cervical Cancer Treatments
- Electronic Health Records Systems
- Patient Satisfaction in Healthcare
- Patient-Provider Communication in Healthcare
- Urological Disorders and Treatments
- Digital Imaging in Medicine
Norwegian University of Science and Technology
2016-2025
Cancer Registry of Norway
2022-2025
Norwegian Institute of Public Health
2025
Abstract Background Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase among long-term non-attenders Norway. Methods A pragmatic randomised controlled trial with as the primary outcome was initiated national cervical programme March 2019. random sample of 6000 women aged 35–69 years who had not attended for at least 10 were 1:1:1 to receive either (i) a reminder attend regular (control), (ii) an...
We evaluated colposcopy in the routine diagnostic workup of women with abnormal cervical cytology, as well value endocervical curettage material and biopsies taken from colposcopy-positive colposcopy-negative quadrants cervix.This cross-sectional study included 297 nonpregnant cytology no prior treatment for dysplasia or cancer. All underwent gynecological examination, colposcopy, curettage, had taken. Colposcopy was considered satisfactory if squamocolumnar junction fully visible, were all...
Background Cervical intraepithelial neoplasia grade 1 (CIN1) is often managed by active surveillance, as the risk of progression to high lesions reported be low, but long-term data sparse. To inform management CIN1, we estimated and occurrence treatment in women attending a cervical cancer screening program. Methods We used nationwide, registry on all aged 25–69 years Norwegian Cancer Screening Program 2002–2019. The eligible source population was with at least one cytology registration (n =...
Anyplex II HPV28 (`Anyplex`) is a semi-quantitative DNA PCR assay divided into set A, comprising 14 high risk (hr)HPV types; and B, 5 possibly hrHPV types 9 low (lr)HPV types. We compared the ability of to that Hybrid Capture 2 (HC2) PreTect HPV-Proofer (`Proofer`) detect cervical intraepithelial neoplasia grade two or worse (CIN2+) by HPV viral load. This cross-sectional study included 296 women referred colposcopy with abnormal cytology and/or persistent infection. CIN2+ was identified in...
Background and Study Aims: In the process of revising our written patient information, we wanted to incorporate some feedback into text, compare new brochures with old one in terms procedure-related anxiety general satisfaction.
The association between cervical cancer screening and reduction of has been dealt with in much research. However, little published on the mortality. We assessed deaths according to history, histopathology, age among women in, under, above age.In this nationwide, registry-based case-control study from Norway, we included 817 diagnosed period 1998-2009. matched each case 10 population-based controls free cancer, obtained by density-based sampling. Odds ratios (ORs) 95% confidence intervals...
Objective To explore Norwegian general practitioners’ (GPs) experiences with the changes in cervical cancer screening programme and to uncover which aspects of they find most challenging.Design We conducted an electronic cross-sectional survey.Setting GPs were invited participate survey between February September 2020.Subjects One hundred fifty-five 429 responded.Main outcome measures Self-reported used analyse beliefs related programme.Results Most did not it particularly challenging keep...
Abstract Background The main aim of the present study is to assess whether human papillomavirus (HPV) self-sampling may increase cervical cancer screening participation among long-term non-attenders in Norway. Methods A pragmatic randomized controlled trial was initiated national programme March 2019. random sample 6000 women aged 35-69 years who had not attended for at least 10 were 1:1:1 receive either (i) a reminder attend regular (control arm), (ii) an offer order kit (opt-in or (iii)...